Concepedia

Kristy Shield‐Artin

KS

8

Publications

1.3K

Citations

8

H-Index

2012

Active since

Affiliations

The University of Melbourne(Current)

Walter and Eliza Hall Institute of Medical Research

Monash University

Baker Heart and Diabetes Institute

Peter MacCallum Cancer Centre

Kristy Shield‐Artin is an author at The University of Melbourne specializing in cell biology, cell signaling, and cell death.

ORCID

Top concepts

Publications per year

2012–2023

8

Publications

8

Secondary Somatic Mutations Restoring <i>RAD51C</i> and <i>RAD51D</i> Associated with Acquired Resistance to the PARP Inhibitor Rucaparib in High-Grade Ovarian Carcinoma

Olga Kondrashova, Minh Nguyen, Kristy Shield‐Artin et al. · Cancer Discovery · 2017 · 396 citations · Full text

MLKL trafficking and accumulation at the plasma membrane control the kinetics and threshold for necroptosis

André L. Samson, Ying Zhang, Niall D. Geoghegan et al. · Nature Communications · 2020 · 335 citations · Full text

Mutations that prevent caspase cleavage of RIPK1 cause autoinflammatory disease

Najoua Lalaoui, Steven E. Boyden, Hirotsugu Oda et al. · Nature · 2019 · 316 citations · Full text

, , +9

Acquired <i>RAD51C</i> Promoter Methylation Loss Causes PARP Inhibitor Resistance in High-Grade Serous Ovarian Carcinoma

Ksenija Nesic, Olga Kondrashova, Rachel M. Hurley et al. · Cancer Research · 2021 · 82 citations · Full text

Oligomerization‐driven MLKL ubiquitylation antagonizes necroptosis

Zikou Liu, Laura F. Dagley, Kristy Shield‐Artin et al. · The EMBO Journal · 2021 · 70 citations · Full text

, , +6

Rows per page

1–5 of 8